Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Increased levels of low-density lipoproteins are the main risk factor in the initiation and progression of atherosclerosis. Although statin treatment can effectively lower these levels, there is still a residual risk of cardiovascular events. We hypothesize that a specific panel of stress-sensing molecules (alarmins) could indicate the persistence of silent atherosclerosis residual risk. New Zealand White rabbits were divided into: control group (C), a group that received a high-fat diet for twelve weeks (Au), and a treated hyperlipidemic group with a lipid diet for eight weeks followed by a standard diet and hypolipidemic treatment (atorvastatin and PCSK9 siRNA-inhibitor) for four weeks (Asi). Mass spectrometry experiments of left ventricle lysates were complemented by immunologic and genomic studies to corroborate the data. The hyperlipidemic diet determined a general alarmin up-regulation tendency over the C group. A significant spectral abundance increase was measured for specific heat shock proteins, S100 family members, HMGB1, and Annexin A1. The hypolipidemic treatment demonstrated a reversed regulation trend with non-significant spectral alteration over the C group for some of the identified alarmins. Our study highlights the discriminating potential of alarmins in hyperlipidemia or following hypolipidemic treatment. Data are available via ProteomeXchange with identifier PXD035692.
Funding Information
  • Romanian Academy (PN-III-P1-1.1-TE-2021-1161, PN-III-P4-PCE-2021-1344)
  • Romanian National Authority for Scientific Research and Innovation (PN-III-P1-1.1-TE-2021-1161, PN-III-P4-PCE-2021-1344)
  • Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (PN-III-P1-1.1-TE-2021-1161, PN-III-P4-PCE-2021-1344)

This publication has 44 references indexed in Scilit: